Latest GlaxoSmithKline Stories
In its latest May 2014 survey, polyDNA found that 68% of respondents did not know if the same antiviral treatments are used against genital and oral herpes infections.
LONDON, May 13, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
polyDNA’s newest survey for the month of May discovered that 36% of respondents with arthritis wanted to know if EBV is the cause of their disease.
For more information about this release, please scroll to bottom. NEW YORK, May 9, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding
LONDON, May 7, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Biotech Leadership with Significant Strategic and Financial Expertise SAN DIEGO, May 6, 2014 /PRNewswire/ -- Arcturus
LONDON, April 30, 2014 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Incruse(TM) Ellipta(®) (umeclidinium)
LONDON, April 30, 2014 /PRNewswire/ -- SOURCE GlaxoSmithKline
LONDON, April 29, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
- A political dynamiter.